vital burn glp-1 Daily Support Fiber Prescription GLP-1s for Weight Loss
Description
(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who take GLP-1 medications are about 30% less likely to develop breast cancer than those who do not take GLP-1 medications.
The more meaningful question is not: Do patients regain weight after stopping GLP-1s? It is: How should we transition patients from pharmacologic support to long-term weight maintenance? Obesity is a chronic disease
This is for the man or woman who takes gut health seriously who understands that the microbiome is the foundation of metabolic health, appetite regulation and digestive wellbeing and wants the most scientifically advanced probiotic formula available featuring the breakthrough strain that standard probiotic brands cannot deliver
GLP-1 agonists work by regulating appetite hormones and blood sugar, addressing both menopause-specific weight gain and metabolic slowdown
Do not start a GLP-1 receptor agonist in a patient with a prior diagnosis of gastroparesis
